Dilated Cardiomyopathy: Genetic Determinants and Mechanisms

Cited by (791)

Items 101–200 of 791

1. Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression
   Vittoria Marini, Fabiola Marino, Flaminia Aliberti, Nefele Giarratana, Enrico Pozzo, Robin Duelen, Álvaro Cortés Calabuig, Rita La Rovere, Tim Vervliet, Daniele Torella et al. · 2022 · Frontiers in Cell and Developmental Biology
2. Integrative Single-Cell Analysis of Cardiomyopathy Identifies Differences in Cell Stemness and Transcriptional Regulatory Networks among Fibroblast Subpopulations
   Wenyang Nie, Zhijie Zhao, Yuhang Liu, Youcao Wang, Jingwen Zhang, Ying Hu, Yang Liu, Yong Wang, Zhen Wang · 2024 · Cardiology Research and Practice
3. LncRNA DCRT Protects Against Dilated Cardiomyopathy by Preventing NDUFS2 Alternative Splicing by Binding to PTBP1
   Hengzhi Du, Yanru Zhao, Jianpei Wen, Beibei Dai, Guo Hu, Yufei Zhou, Zhongwei Yin, Nan Ding, Huaping Li, Jiahui Fan et al. · 2024 · Circulation
4. Alternative splicing in cardiomyopathy
   Abdelaziz Beqqali · 2018 · Biophysical Reviews
5. Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies
   Ali J. Marian, Babken Asatryan, Xander H.T. Wehrens · 2020 · Cardiovascular Research
6. Prevalence and Prognostic Impact of Pathogenic Variants in Patients With Dilated Cardiomyopathy Referred for Ventricular Tachycardia Ablation
   Micaela Ebert, Adrianus P. Wijnmaalen, Marta Riva, Serge A.I.P. Trines, Alexander F.A. Androulakis, Claire A. Glashan, Martin Jan Schalij, J. Peter van Tintelen, Jan D.H. Jongbloed, Katja Zeppenfeld · 2020 · JACC. Clinical electrophysiology
7. Overview of Cardiomyopathies in Childhood
   Anika Rath, Robert Gideon Weintraub · 2021 · Frontiers in Pediatrics
8. Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction
   Daniel Auguin, Julien Robert‐Paganin, S. Réty, Carlos Massayuki Kikuti, Amandine David, Gabriele Theumer, Arndt W. Schmidt, Hans‐Joachim Knölker, Anne Houdusse · 2024 · Nature Communications
9. A missense mutation in the RSRSP stretch of Rbm20 causes dilated cardiomyopathy and atrial fibrillation in mice
   Kensuke Ihara, Tetsuo Sasano, Yuichi Hiraoka, Marina Togo‐Ohno, Yurie Soejima, Motoji Sawabe, Megumi Tsuchiya, Hidesato Ogawa, Tetsushi Furukawa, Hidehito Kuroyanagi · 2020 · Scientific Reports
10. Neutrophil Extracellular Traps in Myocardial Tissue Drive Cardiac Dysfunction and Adverse Outcomes in Patients With Heart Failure With Dilated Cardiomyopathy
    Shohei Ichimura, Tomofumi Misaka, Ryo Ogawara, Yusuke Tomita, Fumiya Anzai, Yu Sato, Shunsuke Miura, Tetsuro Yokokawa, Takamasa Sato, Masayoshi Oikawa et al. · 2024 · Circulation Heart Failure
11. The transcriptional repressor HEY2 regulates mitochondrial oxidative respiration to maintain cardiac homeostasis
    Peilu She, Bangjun Gao, Dongliang Li, Chen Wu, Xuejiao Zhu, Yuan He, Fei Mo, Yao Qi, Daqing Jin, Yewei Chen et al. · 2025 · Nature Communications
12. Recent progress of iPSC technology in cardiac diseases
    Shunsuke Funakoshi, Yoshinori Yoshida · 2021 · Archives of Toxicology
13. Inherited Arrhythmias in the Pediatric Population: An Updated Overview
    Marco Valerio Mariani, Nicola Pierucci, Francesca Fanisio, Domenico Laviola, Giacomo Silvetti, Agostino Piro, Vincenzo Mirco La Fazia, Cristina Chimenti, Marco Rebecchi, Fabrizio Drago et al. · 2024 · Medicina
14. An introduction to "Water in the cell": tamed Hydra?
    Pascale Mentré · 2001 · PubMed
15. At the heart of inter- and intracellular signaling: the intercalated disc
    Heather R. Manring, Lisa E. Dorn, Aidan Ex-Willey, Federica Accornero, Maegen A. Ackermann · 2018 · Biophysical Reviews
16. Reconstruction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA Reveal Functional lncRNAs in Dilated Cardiomyopathy
    Lichan Tao, Ling Yang, Xiaoli Huang, Fei Hua, Xiaoyu Yang · 2019 · Frontiers in Genetics
17. Emerging Techniques for Risk Stratification in Nonischemic Dilated Cardiomyopathy
    Benjamin Marrow, Stuart A. Cook, Sanjay Kumar Prasad, Gerry Patrick McCann · 2020 · Journal of the American College of Cardiology
18. Diagnostic and prognostic value of low QRS voltages in cardiomyopathies: old but gold
    Francesca Valentini, Francesca Anselmi, Marco Metra, Luna Cavigli, Elisa Giacomin, Marta Focardi, Matteo Cameli, Sergio Mondillo, Flavio D’Ascenzi · 2020 · European Journal of Preventive Cardiology
19. Renin Activity in Heart Failure with Reduced Systolic Function—New Insights
    Ryan D. Sullivan, Radhika M. Mehta, Ranjana Tripathi, Guy L. Reed, Inna P. Gladysheva · 2019 · International Journal of Molecular Sciences
20. Metabolic Alterations in Inherited Cardiomyopathies
    Claudia Sacchetto, Vasco Sequeira, Edoardo Bertero, Jan Dudek, Christoph Maack, Martina Calore · 2019 · Journal of Clinical Medicine
21. German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management
    Dierk Thomas, Torsten Christ, Larissa Fabritz, Andreas Goette, Matthias Hammwöhner, Jordi Heijman, Jens Kockskämper, Dominik Linz, Katja E. Odening, Patrick A. Schweizer et al. · 2018 · Clinical Research in Cardiology
22. Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance
    Panagiota Mitropoulou, Georgios A. Georgiopoulos, Stefano Figliozzi, Dimitrios Klettas, Flavia Nicoli, Pier Giorgio Masci · 2020 · Frontiers in Cardiovascular Medicine
23. Genetics of dilated cardiomyopathy
    Suet Nee Chen, Luisa Mestroni, Matthew R.G. Taylor · 2021 · Current Opinion in Cardiology
24. Mitochondrial Protein Homeostasis and Cardiomyopathy
    Emily Wachoski-Dark, Tian Zhao, Aneal Khan, Timothy E. Shutt, Steven C. Greenway · 2022 · International Journal of Molecular Sciences
25. Genetic Testing in Hypertrophic Cardiomyopathy
    Catherine Gorman Ireland, Carolyn Yung Ho · 2024 · The American Journal of Cardiology
26. Dilated cardiomyopathies and non-compaction cardiomyopathy
    Anja Hänselmann, Christian Veltmann, Johann K Bauersachs, Dominik Berliner · 2020 · Herz
27. Genetic variants of uncertain significance: How to match scientific rigour and standard of proof in sudden cardiac death?
    S. Grassi, Ó. Campuzano, M. Coll, M. Brion, V. Arena, Anna Iglesias, Á. Carracedo, R. Brugada, Antonio Oliva · 2020 · Legal Medicine
28. Predictive genomic tools in disease stratification and targeted prevention: a recent update in personalized therapy advancements
    Neha Jain, Upendra Nagaich, Manisha Pandey, Dinesh Kumar Chellappan, Kamal Dua · 2022 · The EPMA Journal
29. ESC EORP Cardiomyopathy Registry: Real-Life Practice of Genetic Counselling and Testing in Adult Cardiomyopathy Patients
    Tiina M. Heliö, Perry M Elliot, Juha W. Koskenvuo, Juan Ramón Gimeno, Luigi Tavazzi, Michał Tendera, Juan Pablo Kaski, Nicolas Mansencal, Zofia T. Bilińska, Gerry Carr‐White et al. · 2020 · ESC Heart Failure
30. Epigenetics in LMNA-Related Cardiomyopathy
    Yinuo Wang, Gergana D. Dobreva · 2023 · Cells
31. Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3
    Cristine J. Reitz, Marjan Tavassoli, Da Hye Kim, Saumya Shah, Robert Lakin, Allen C. T. Teng, Yuqing Zhou, Wenping Li, Sina Hadipour‐Lakmehsari, Peter H. Backx et al. · 2023 · Proceedings of the National Academy of Sciences
32. Dilated cardiomyopathy caused by truncating titin variants: long-term outcomes, arrhythmias, response to treatment and sex differences
    Christoffer Rasmus Vissing, Torsten B. Rasmussen, Anne Mette Dybro, MORTEN SALLING OLESEN, Lisbeth Noerum Pedersen, Morten K. Jensen, Henning Bundgaard, Alex Hørby Christensen · 2020 · Journal of Medical Genetics
33. Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation
    Petr G. Vikhorev, Natalia N. Vikhoreva, WaiChun Yeung, Amy S. Li, Sean Lal, Cristobal G. dos Remedios, Cheavar A. Blair, Maya E. Guglin, Kenneth S. Campbell, Magdi Habib Yacoub et al. · 2020 · Cardiovascular Research
34. Pathobiology of cardiovascular diseases: an update
    Louis Maximilian Buja, Giulia Ottaviani, MD, PhD, Richard N. Mitchell · 2019 · Cardiovascular Pathology
35. Meta-Analysis of Dilated Cardiomyopathy Using Cardiac RNA-Seq Transcriptomic Datasets
    Ahmad Alimadadi, Patricia B. Munroe, Bina Joe, Xi Cheng · 2020 · Genes
36. Increased cytosolic calcium buffering contributes to a cellular arrhythmogenic substrate in iPSC-cardiomyocytes from patients with dilated cardiomyopathy
    Philipp Jung, Fitzwilliam Seibertz, Funsho E. Fakuade, Nadezda Ignatyeva, Shrivatsan Sampathkumar, Melanie Ritter, Housen Li, Fleur E. Mason, Antje Ebert, Niels Voigt · 2022 · Basic Research in Cardiology
37. Sudden Cardiac Death in the Young: State-of-the-Art Review in Molecular Autopsy
    Cecilia Salzillo, Vincenza Sansone, Francesco Napolitano · 2024 · Current Issues in Molecular Biology
38. An Update on Pediatric Cardiomyopathy
    Swati Choudhry, Kriti Puri, Susan W. Denfield · 2019 · Current Treatment Options in Cardiovascular Medicine
39. Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine
    Michael J. Greenberg, Jil C. Tardiff · 2021 · The Journal of General Physiology
40. Circulating circRNA as biomarkers for dilated cardiomyopathy etiology
    Marina C. Costa, María Calderón‐Domínguez, Alipio Mangas, Óscar Campuzano, Georgia Sarquella‐Brugada, Mónica Ramos, Maribel Quezada-Feijoó, José Manuel García Pinilla, Ainhoa Robles Mezcua, Galan del Aguila Pacheco-Cruz et al. · 2021 · Journal of Molecular Medicine
41. Phenotyping cardiomyopathy in adult zebrafish
    Alexey V. Dvornikov, Pieter P. de Tombe, Xiaolei Xu · 2018 · Progress in Biophysics and Molecular Biology
42. Functional enrichment of alternative splicing events with NEASE reveals insights into tissue identity and diseases
    Zakaria Louadi, Maria L. Elkjaer, Melissa Klug, Chit Tong Lio, Amit M. Fenn, Zsolt Illés, Dario Bongiovanni, Jan Baumbach, Tim Kacprowski, Markus List et al. · 2021 · Genome biology
43. PRMT5 Prevents Dilated Cardiomyopathy via Suppression of Protein O-GlcNAcylation
    Zhenhua Li, Jingping Xu, Yao Song, Chong Xin, Lantao Liu, Ning Hou, Yan Teng, Xuan Cheng, Tianle Wang, Zhenyang Yu et al. · 2021 · Circulation Research
44. Depletion of m6A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin
    Siyun Gao, Haifeng Sun, Kejing Chen, Xueying Gu, Hongyu Chen, Liudan Jiang, Lei Chen, Shengqi Zhang, Yi Liu, Dan Shi et al. · 2021 · Journal of Cellular and Molecular Medicine
45. The harder the climb the better the view: The impact of substrate stiffness on cardiomyocyte fate
    Silvia Querceto, Rosaria Santoro, Aoife Gowran, Bruno Grandinetti, Giulio Pompilio, Michael Regnier, Chiara Tesi, Corrado Poggesi, Cecilia Ferrantini, Josè Manuel Pioner · 2022 · Journal of Molecular and Cellular Cardiology
46. Integrated analysis of WGCNA and machine learning identified diagnostic biomarkers in dilated cardiomyopathy with heart failure
    Yihao Zhu, Xiaojing Yang, Yao Zu · 2022 · Frontiers in Cell and Developmental Biology
47. Dilated cardiomyopathy mutation E525K in human beta-cardiac myosin stabilizes the interacting-heads motif and super-relaxed state of myosin
    David V. Rasicci, Prince Tiwari, Skylar M.L. Bodt, Rohini D. Desetty, Fredrik W. Sadler, Sivaraj Sivaramakrishnan, Roger W. Craig, Christopher M. Yengo · 2022 · eLife
48. Loss of hepatic PPARα in mice causes hypertension and cardiovascular disease
    Olufunto Olayinka Badmus, Zachary A. Kipp, Evelyn A. Bates, Alexandre A. da Silva, Lucy C. Taylor, Genesee J. Martinez, Wang‐Hsin Lee, Justin F. Creeden, Terry D. Hinds, David E. Stec · 2023 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
49. RBPMS regulates cardiomyocyte contraction and cardiac function through RNA alternative splicing
    Peiheng Gan, Zhaoning Wang, Svetlana Bezprozvannaya, John McAnally, Wei Hong Tan, Hui zi Li, Rhonda Bassel‐Duby, Ning Liu, Eric N. Olson · 2023 · Cardiovascular Research
50. Pediatric dilated cardiomyopathy: a review of current clinical approaches and pathogenesis
    Ian Malinow, Daniel C. Fong, Matthew Miyamoto, Sarah Badran, Charles C. Hong · 2024 · Frontiers in Pediatrics
51. Late gadolinium enhancement imaging and sudden cardiac death
    Sanjay Kumar Prasad, Tamim Akbari, Martin J. Bishop, Brian P. Halliday, Francisco Leyva, Francis E. Marchlinski · 2025 · European Heart Journal
52. Novel polymorphisms in PDLIM3 and PDLIM5 gene encoding Z ‐line proteins increase risk of idiopathic dilated cardiomyopathy
    Dongfei Wang, Juan Fang, Jialan Lv, Zhicheng Pan, Xiang Yin, Hongqiang Cheng, Xiaogang Guo · 2019 · Journal of Cellular and Molecular Medicine
53. The Cardiac Lipidome in Models of Cardiovascular Disease
    Mateusz M. Tomczyk, Vernon Wayne Dolinsky · 2020 · Metabolites
54. The intrinsically disordered C terminus of troponin T binds to troponin C to modulate myocardial force generation
    Jamie R. Johnston, Maicon Landim-Vieira, Mayra A. Marques, Guilherme A. P. de Oliveira, David Gonzalez-Martinez, Adolfo Henrique Moraes, Huan He, Anwar Iqbal, Yael Wilnai, Einat Birk et al. · 2019 · Journal of Biological Chemistry
55. Dilated Cardiomyopathy: From Genetics to Clinical Management
    2019
56. Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk
    Seung Hoan Choi, Sean Joseph Jurgens, Ling Xiao, Matthew C. Hill, Christopher M. Haggerty, Garðar Sveinbjörnsson, Valerie N. Morrill, Nicholas Marston, Lu-Chen C Weng, James P. Pirruccello et al. · 2025 · Nature Genetics
57. A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy
    Claire Horvat, Renée Johnson, Lien Lam, Jacob E. Munro, Francesco Mazzarotto, Angharad M. Roberts, Daniel S. Herman, Michael G. Parfenov, Alireza Haghighi, Barbara A. McDonough et al. · 2018 · Genetics in Medicine
58. Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy
    Gherardo Finocchiaro, Harshil Dhutia, Belinda R. Gray, Bode Ensam, Efstathios Papatheodorou, Chris J. Miles, Aneil Malhotra, Zephryn Fanton, Paulo Angelo Bulleros, Tessa Homfray et al. · 2020 · EP Europace
59. Machine learning-based classification and diagnosis of clinical cardiomyopathies
    Ahmad Alimadadi, Ishan Manandhar, Sachin Aryal, Patricia B. Munroe, Bina Joe, Xi Cheng · 2020 · Physiological Genomics
60. Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity
    Jui‐Ning Yeh, Ya Yue, Yi‐Ching Chu, Chi‐Ruei Huang, Chih‐Chao Yang, John Y. Chiang, Hon‐Kan Yip, Jun Guo · 2021 · Biomedicine & Pharmacotherapy
61. Genetically determined cardiomyopathies at autopsy: the pivotal role of the pathologist in establishing the diagnosis and guiding family screening
    Mary Noelle Sheppard, Allard C. van der Wal, Jytte Banner, Giulia d’Amati, Monica De Gaspari, Rosa De Gouveia, Cira Rosaria Tiziana Di Gioia, Carla Giordano, Maiken Kudahl Larsen, Matthew Lynch et al. · 2023 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
62. Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAs
    Gelsomina Mansueto, Giuditta Benincasa, Nunzia Della Mura, Giovanni Francesco Nicoletti, Claudio Napoli A · 2020 · Journal of Clinical Pathology
63. Nuclear damage in LMNA mutant iPSC-derived cardiomyocytes is associated with impaired lamin localization to the nuclear envelope
    Melanie Wallace, Hind C. Zahr, Shriya Perati, Chloé D. Morsink, Lindsey E. Johnson, Anthony M. Gacita, Shuping Lai, Lori L. Wallrath, Ivor J. Benjamin, Elizabeth M. McNally et al. · 2023 · Molecular Biology of the Cell
64. Current RNA strategies in treating cardiovascular diseases
    Shirley Pei Shan Chia, Jeremy Kah Sheng Pang, Boon-Seng Soh · 2024 · Molecular Therapy
65. Genomic analysis of circular RNAs in heart
    Kunzhe Dong, Xiangqin He, Huabo Su, David J. Fulton, Jiliang Zhou · 2020 · BMC Medical Genomics
66. The Sarcomeric Spring Protein Titin: Biophysical Properties, Molecular Mechanisms, and Genetic Mutations Associated with Heart Failure and Cardiomyopathy
    Ramone Eldemire, Charles A. Tharp, Matthew R.G. Taylor, Orfeo Sbaizero, Luisa Mestroni · 2021 · Current Cardiology Reports
67. Deletion of the Lmna gene in fibroblasts causes senescence-associated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype
    Leila Rouhi, Gaelle E Auguste, Qiong Zhou, Raffaella Lombardi, Melis Olcum, Kimia Pourebrahim, Sirisha M. Cheedipudi, Saman Asghar, Kui Hong, Matthew J. Robertson et al. · 2022 · The Journal of Cardiovascular Aging
68. Clinical and Molecular Implications of Osteopontin in Heart Failure
    Argen Mamazhakypov, Meerim Sartmyrzaeva, Сарыбаев Акпай Шогаибович, RALPH THEO SCHERMULY, Akylbek S. Sydykov · 2022 · Current Issues in Molecular Biology
69. RIKADA Study Reveals Risk Factors in Pediatric Primary Cardiomyopathy
    Nadya Al‐Wakeel‐Marquard, F. Degener, Christopher Herbst, Jirko Kühnisch, Josephine Dartsch, Boris Schmitt, Titus Kühne, Daniel Messroghli, Felix F. Berger, Sabine Klaassen · 2019 · Journal of the American Heart Association
70. Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2 in Ischemic and Non-Ischemic Heart Failure
    Gilda Varricchi, Stefania Loffredo, Leonardo Bencivenga, Anne Lise Ferrara, Giuseppina Gambino, Nicola Ferrara, Amato de Paulis, Gianni Marone, Giuseppe Rengo · 2020 · Journal of Clinical Medicine
71. Update on the Diagnostic Pitfalls of Autopsy and Post-Mortem Genetic Testing in Cardiomyopathies
    Simone Grassi, Óscar Campuzano, Mónica Coll, Francesca Cazzato, Georgia Sarquella‐Brugada, Riccardo Rossi, Vincenzo Arena, Josép Brugada, Ramón Brugada, Antonio Oliva · 2021 · International Journal of Molecular Sciences
72. LncRNA CHKB-DT Downregulation Enhances Dilated Cardiomyopathy Through ALDH2
    Xiang Nie, Jiahui Fan, Beibei Dai, Wen Zheng, Huaping Li, Chen Chen, Dao Wen Wang · 2024 · Circulation Research
73. Rare genetic mutations in Pakistani patients with dilated cardiomyopathy
    Muhammad Shakeel, Muhammad Irfan, Ishtiaq Ahmad Khan · 2018 · Gene
74. Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques
    Aldostefano Porcari, Giulia De Angelis, Simona Romani, Alessia Paldino, Jessica Artico, Antonio Nicola Cannata, Piero Gentile, Bruno Pinamonti, Marco Merlo, Gianfranco Sinagra · 2018 · Expert Review of Cardiovascular Therapy
75. Current Advances in Immunomodulatory Biomaterials for Cell Therapy and Tissue Engineering
    Boram Kim, Lipi Pradhan, Andrea Hernández, Devyani Yenurkar, Susheel Kumar Nethi, Sudip Mukherjee · 2023 · Advanced Therapeutics
76. Mutation in FBXO32 causes dilated cardiomyopathy through up-regulation of ER-stress mediated apoptosis
    Nadya Al‐Yacoub, Dilek Çolak, Salma Mahmoud Awad, Maya Hammonds, Muhammed Kunhi, Olfat Al‐Harazi, Abdullah M. Assiri, Jehad Alburaiki, Waleed AlHabeeb, Coralie I Poizat · 2021 · Communications Biology
77. Exosomes mediated fibrogenesis in dilated cardiomyopathy through a MicroRNA pathway
    Xuebin Fu, Rachana Mishra, Ling Chen, Mir Yasir Arfat, Sudhish Sharma, Tami J. Kingsbury, Muthukumar Gunasekaran, Progyaparamita Saha, Charles C. Hong, Peixin Yang et al. · 2023 · iScience
78. Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy
    Yuko Iwata, Tsuyoshi Matsumura · 2019 · International Journal of Molecular Sciences
79. Clinical Insights Into Heritable Cardiomyopathies
    Hugo R. Martinez, Gary S. Beasley, Noah Miller, Jason F. Goldberg, John L. Jefferies · 2021 · Frontiers in Genetics
80. LMNA Cardiomyopathy: Important Considerations for the Heart Failure Clinician
    Karen Flores Rosario, Ravi Karra, Kaitlyn Amos, Andrew Paul Landstrom, Neal K. Lakdawala, Kyla Brezitski, Han Kim, Adam D. DeVore · 2023 · Journal of Cardiac Failure
81. Mechanisms of RBM20 Cardiomyopathy: Insights From Model Systems
    Zachery R. Gregorich, Yanghai Zhang, Timothy J. Kamp, Henk L. M. Granzier, Wei Guo · 2024 · Circulation Genomic and Precision Medicine
82. Myosins and Disease
    Lynne M. Coluccio · 2020 · Advances in experimental medicine and biology
83. Modulating the tension-time integral of the cardiac twitch prevents dilated cardiomyopathy in murine hearts
    Joseph D. Powers, Kristina Bezold Kooiker, Allison B. Mason, Abigail E. Teitgen, Galina V. Flint, Jil C. Tardiff, Steven D. Schwartz, Andrew D. McCulloch, Michael Regnier, Jennifer Davis et al. · 2020 · JCI Insight
84. Evaluation of extracellular volume by computed tomography is useful for prediction of prognosis in dilated cardiomyopathy
    Satomi Yashima, Hiroyuki Takaoka, Togo Iwahana, Yusei Nishikawa, Joji Ota, Shuhei Aoki, Makiko Kinoshita, Manami Takahashi, Haruka Sasaki, Noriko Suzuki-Eguchi et al. · 2022 · Heart and Vessels
85. Considering complexity in the genetic evaluation of dilated cardiomyopathy
    Elizabeth Jordan, Ray E. Hershberger · 2020 · Heart
86. Actin-associated proteins and cardiomyopathy—the ‘unknown’ beyond troponin and tropomyosin
    Elisabeth Ehler · 2018 · Biophysical Reviews
87. Role of Cardiac Imaging: Echocardiography
    Bruno Pinamonti, Elena Abate, Antonio De Luca, Gherardo Finocchiaro, Renata Korcova · 2019 · Springer eBooks
88. Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes: Implications for disease modeling and maturation
    Patrick J. Ernst, Philip A. Bidwell, Michaela Dora, David Dale Thomas, Forum D. Kamdar · 2023 · Frontiers in Cell and Developmental Biology
89. Hippo pathway activation mediates cardiomyocyte ferroptosis to promote dilated cardiomyopathy through downregulating NFS1
    Gang She, Xia-Xia Hai, Li-Ye Jia, Yongjian Zhang, Yujie Ren, Zheng‐Da Pang, Lihua Wu, Meng-Zhuan Han, Yu Zhang, Jingjing Li et al. · 2025 · Redox Biology
90. A Comprehensive Outlook on Dilated Cardiomyopathy (DCM): State-Of-The-Art Developments with Special Emphasis on OMICS-Based Approaches
    Vivek Sarohi, Shriya Srivastava, Trayambak Basak · 2022 · Journal of Cardiovascular Development and Disease
91. Emerging Genotype–Phenotype Associations in Dilated Cardiomyopathy
    Joyce Nyaucha Njoroge, Jennifer C. Mangena, Chiaka N Aribeana, Victoria Nicole Parikh · 2022 · Current Cardiology Reports
92. Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patients
    Krista Heliö, Marcos Cicerchia, Julie Hathaway, Johanna Tommiska, Johanna M. Huusko, Inka Saarinen, Lotta Koskinen, Mikko Muona, Ville Kytölä, Janica Djupsjöbacka et al. · 2023 · Frontiers in Cardiovascular Medicine
93. Mitochondrial genome variations in idiopathic dilated cardiomyopathy
    Periyasamy Govindaraj, Bindu Rani, Pandarisamy Sundaravadivel, Ayyasamy Vanniarajan, K. P. Indumathi, Nahid Akthar Khan, Perundurai Subramaniam Dhandapany, Deepa Selvi Rani, Rakesh Tamang, Ajay Bahl et al. · 2019 · Mitochondrion
94. Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy
    Rowida Almomani, Johanna C. Herkert, Anna Pósafalvi, Jan G. Post, Ludolf G. Boven, Paul A. van der Zwaag, Peter H.G.M. Willems, Ingrid H. Hof, Judith M. A. Verhagen, Marja W. Wessels et al. · 2019 · Journal of Medical Genetics
95. Haploinsufficiency of mechanistic target of rapamycin ameliorates bag3 cardiomyopathy in adult zebrafish
    Yonghe Ding, Alexey V. Dvornikov, Xiao Ma, Hong Zhang, Yong Wang, Matthew R. Lowerison, René R. Sevag Packard, Lei Wang, Jun Chen, Yuji Zhang et al. · 2019 · Disease Models & Mechanisms
96. Functions of RNA-Binding Proteins in Cardiovascular Disease
    Grégoire Ruffenach, Lejla Medzikovic, Wasila Sun, Jason S. Hong, Mansoureh Eghbali · 2023 · Cells
97. Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients With Sporadic Dilated Cardiomyopathy
    Lei Xiao, Chenze Li, Yang Sun, Yanghui Chen, Haoran Wei, Dong Hu, Ting Yu, Xianqing Li, Jin Li, Leming M. Shi et al. · 2021 · Frontiers in Cardiovascular Medicine
98. The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing
    Lingqun Ye, Xuan Ni, Zhen‐Ao Zhao, Wei Lei, Shijun Hu · 2018 · Journal of Cardiovascular Translational Research
99. Reduced myocyte complex N ‐glycosylation causes dilated cardiomyopathy
    Andrew R. Ednie, Wei Deng, Kay‐Pong Yip, Eric S. Bennett · 2018 · The FASEB Journal
100. Minimal inflammatory foci of unknown etiology may be a tentative sign of early stage inherited cardiomyopathy
     Yukiko Hata, Keiichi Hirono, Yoshiaki Yamaguchi, Fukiko Ichida, Yuko Oku, Naoki Nishida · 2019 · Modern Pathology